Hoya Corp. (OTCMKTS:HOCPY - Get Free Report)'s stock price reached a new 52-week high on Monday . The company traded as high as $152.85 and last traded at $151.08, with a volume of 47682 shares trading hands. The stock had previously closed at $146.04.
Analysts Set New Price Targets
HOCPY has been the subject of a number of analyst reports. Nomura Securities raised Hoya to a "strong-buy" rating in a research note on Monday, August 18th. The Goldman Sachs Group raised Hoya from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, July 23rd. Three investment analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat, the company currently has a consensus rating of "Strong Buy".
Read Our Latest Report on Hoya
Hoya Price Performance
The business has a 50 day moving average of $134.78 and a 200 day moving average of $123.46. The company has a market cap of $52.05 billion, a PE ratio of 37.93, a price-to-earnings-growth ratio of 3.12 and a beta of 1.03. The company has a debt-to-equity ratio of 0.03, a current ratio of 5.19 and a quick ratio of 4.46.
Hoya (OTCMKTS:HOCPY - Get Free Report) last announced its quarterly earnings results on Friday, August 1st. The technology company reported $1.05 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.01. Hoya had a return on equity of 21.01% and a net margin of 23.57%.The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.47 billion. As a group, research analysts predict that Hoya Corp. will post 3.66 EPS for the current year.
Hoya Company Profile
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.